StemRIM StemRIM

Investor Library

StemRIMIR LibraryTimely Disclosure Information
All Timely Disclosure Information Financial Results Presentation Materials IR News
April 11, 2023 Timely Disclosure Information [Delayed] Notice of Earnings Forecasts for the Fiscal Year Ending July 31, 2023  
April 11, 2023 Timely Disclosure Information [Delayed] StemRIM Announces Milestone Achievement in Development of Therapeutic Drug (Redasemtide) Targeting Acute Ischemic Stroke